4.4 Article

Genetic Lipid Disorders Associated with Atherosclerotic Cardiovascular Disease Molecular Basis to Clinical Diagnosis and Epidemiologic Burden

期刊

MEDICAL CLINICS OF NORTH AMERICA
卷 106, 期 2, 页码 325-+

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2021.11.009

关键词

Cardiovascular disease; Genetics; Hypercholesterolemia; Lipids; Atherosclerosis

向作者/读者索取更多资源

Genetic lipid disorders, including common dyslipidemias such as familial hypercholesterolemia and familial combined hyperlipidemia, affect millions of individuals and often go undiagnosed in the general population. Clinicians should consider the potential of inherited lipid disorders or syndromes when severe derangements in lipid parameters are observed.
Genetic lipid disorders, ranging from common dyslipidemias such as familial hypercholesterolemia, lipoprotein (a), and familial combined hyperlipidemia to rare disorders including familial chylomicronemia syndrome and inherited hypoalphalipoproteinemias (ie, Tangier and fish eye diseases), affect millions of individuals in the United States and tens of millions around the world and are often undiagnosed in the general population. Clinicians should take into consideration the potential of inherited lipid disorders or syndromes when severe derangements in lipid parameters are observed. Patients' combined genotype and phenotype should be evaluated in conjunction with a host of environmental factors impacting their risk of atherosclerotic cardiovascular disease.Genetic lipid disorders, ranging from common dyslipidemias such as familial hypercholesterolemia, lipoprotein (a), and familial combined hyperlipidemia to rare disorders including familial chylomicronemia syndrome and inherited hypoalphalipoproteinemias (ie, Tangier and fish eye diseases), affect millions of individuals in the United States and tens of millions around the world and are often undiagnosed in the general population. Clinicians should take into consideration the potential of inherited lipid disorders or syndromes when severe derangements in lipid parameters are observed. Patients' combined genotype and phenotype should be evaluated in conjunction with a host of environmental factors impacting their risk of atherosclerotic cardiovascular disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据